Quintiles Infosario Receives Computerworld Data+ Editor’s Choice Award

Recognizing data as a strategic asset

RESEARCH TRIANGLE PARK, N.C - Monday, August 26th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Quintiles has been recognized for its pioneering work creating big data solutions that help pharmaceutical organizations improve their probability of success throughout the drug development process, with a Computerworld Data+ Editor’s Choice Award for its Quintiles Infosario® platform.

"The drug development process is predicated upon the availability of high quality data with which to collaborate and make informed decisions at every step of the way during the evolution of a product or treatment," said Quintiles Chief Information Officer Richard Thomas. "We are delighted to receive this award which highlights the work of our outstanding team of dedicated professionals, partners and customers who all contributed in the development of technologies that power our Quintiles Infosario platform."

Quintiles Infosario is an end-to-end suite of technologies that power the pharmaceutical product development process. Making innovative use of advances in big data technologies, Infosario is able to break down silos combining massive quantities of scientific and operational data collected during clinical development with tens of millions of real-world patient medical records and population data. Empowering researchers and drug developers with the knowledge locked in this data improves decision making, and ultimately increases the probability of success at every step in a product’s lifecycle.

Computerworld’s Data+ awards recognize the very best projects that illustrate how big data can be mined and analyzed to predict trends and improve the probability of success. Honorees are being recognized in the August 26th issue of Computerworld, on Computerworld.com and at Computerworld’s 2013 Data+ conference.

“The organizations honored in this year’s Data+ Editor’s Choice awards program have unearthed the business value that’s rooted throughout big data,” said Scot Finnie, editor in chief, Computerworld. “The projects spotlighted are tapping into big data to analyze and influence customer behavior, drive new business revenues and predict future trends. Each of the organizations is raising our understanding of big data to new levels, while at the same time opening the door for other organizations to follow their lead. It’s an exciting time in the big data field.”

About Quintiles

Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com

Click here to subscribe to Mobile Alerts for Quintiles.

Contacts

Quintiles

Media Relations:

Phil Bridges, + 1-919-998-1653

phil.bridges@quintiles.com



Investor Relations:

Karl Deonanan, +1-919-998-2789

InvestorRelations@quintiles.com







Permalink: http://www.me-newswire.net/news/8332/en

Nordson EFD's PICO xMOD Exchangeable/Modular Dispensing Valve Improves Productivity and Reduces Cost

EAST PROVIDENCE, R.I. - Monday, August 26th 2013 [ME NewsWire]

(BUSINESS WIRE) Nordson EFD, a Nordson company (NASDAQ: NDSN), introduces the PICO® xMOD™ Valve, a new and exciting fully exchangeable and modular concept in non-contact and contact needle dispensing of assembly fluids.

Nordson EFD’s PICO xMOD valve system technology uses high-tech, robust, durable piezoelectric actuation technology for continuous operation at speeds of up to 500 cycles/second. The PICO xMOD can produce deposits as small as 2 nanoliters, at high production speeds, with exceptional deposit accuracy and superior process control. The non-contact jet valve makes it possible to apply fluid in hard-to-access areas or onto uneven or delicate substrates for applications in electronics, automotive, life sciences, solar, and a range of other industrial dispensing applications.

All five major xMOD valve components – the Piezo Actuator (PA), the Valve Seat (VS), the Fluid Body (FB), the Cartridge ball/stem assembly (CR), and Heater Set (HS) – are fully interchangeable and easily assembled for each specific application and quickly disassembled for easy cleaning, repair, or maintenance. Each part can be removed and exchanged in seconds, eliminating production down-time and significantly increasing productivity.

“Our new PICO xMOD offers the only tool-free release and installation of the Valve Seat assembly,” explains Claude Bergeron, product line manager, Nordson EFD. “Wetted parts are conveniently and quickly exchanged and serviced. If a part fails, just the worn part needs changing, eliminating the expense of a whole new valve assembly. The ability to swap one xMOD component part for another lets the manufacturer toggle between different applications and fluids, offers flexibility, makes a significant reduction in production down time, and saves time and money.”

Each EFD PICO xMOD component can be individually selected to accommodate particular fluids and applications. All the components are engineered to work together as a complete, integrated system that produces exceptionally fast, accurate deposits of a wide range of fluids.

Industries and Applications for PICO xMOD Dispense Valve include:

Wireless and Display

    UV cure adhesives for bonding (camera modules, keypads, microspeakers, touch pads, and display edge sealing)
    Hydrophobic fluids for protective treatments
    COG (Chip on Glass) and TAB sealing

Electronics

    UV adhesives on mobile speaker membranes
    Fluxes and conformal coatings

Life Sciences/Medical Devices

    Adhesives for bonding needles to hubs
    Bonding of disposable medical device components

Automotive

    Oil and grease dispensing on electrical connectors, gears, and other small part assemblies
    Marking and color coding of parts with ink
    UV adhesive to bond automotive electronic components

Nordson EFD’s PICO xMOD uses the same precision and high quality parts as all Nordson EFD’s PICO valves, maintaining the same high level of dispensing repeatability and precision, while also adding the various benefits of modular exchangeability.

Photo of xMOD available at: http://www.nordsonefd.com/video/PICO/Nordson-EFD-PICO-xMOD.jpg

Animation of xMOD available at: http://www.nordsonefd.com/video/PICO/Nordson-EFD-PICO-xMOD.html

For more information, visit Nordson EFD on the web at www.nordsonefd.com, www.facebook.com/NordsonEFD, or www.linkedin.com/company/nordson-efd, email at info@nordsonefd.com, or call +1 401.431.7000 or 800.556.3484.

Nordson EFD’s PICO xMOD valve will be featured at the following global shows:

Show
                     

Region
                     

Dates

The Assembly Show
                     

USA – Rosemont, IL
                     

Oct. 28-30

Elexcon China
                     

China – Shenzhen
                     

Nov. 16-21

Productronica
                     

Europe – Munich
                     

Nov. 12-15

About Nordson EFD

Nordson EFD designs and manufactures precision fluid dispensing systems for benchtop assembly processes and automated assembly lines. EFD dispensing systems help companies in a wide variety of industries increase throughput, improve quality, and lower production costs. Additional fluid management capabilities include syringe barrels and cartridges for packaging one- and two-component materials and a wide variety of fittings, couplers and connectors for controlling fluid flow in medical, biopharmaceutical, and industrial environments. The company is a leading formulator of specialty solder pastes for dispensing and printing applications in the electronics industry.

About Nordson Corporation

Nordson Corporation (NASDAQ: NDSN) delivers precision technology solutions to help customers succeed worldwide. The company engineers, manufactures and markets differentiated products and systems used for dispensing adhesives, coatings, sealants, biomaterials and other materials, fluid management, test and inspection, UV curing and plasma surface treatment, all supported by application expertise and direct global sales and service. Nordson serves a wide variety of consumer non-durable, durable and technology end markets including packaging, nonwovens, electronics, medical, appliances, energy, transportation, construction, and general product assembly and finishing. Founded in 1954 and headquartered in Westlake, Ohio, the company has operations and support offices in more than 30 countries. Visit Nordson on the web at www.nordson.com, www.twitter.com/Nordson_Corp or www.facebook.com/nordson.

Contacts

Nordson EFD

Rhonda Mitchell, +1 401-431-7065

Strategic Marketing Services Manager

Rhonda.Mitchell@nordsonefd.com



A R Marketing, Inc. (agency)

+1 858-451-8666

andrea@armarketinginc.com







Permalink: http://www.me-newswire.net/news/8328/en

ABThera™ Open Abdomen Negative Pressure Therapy System Study Published in World Journal of Surgery

Significantly Improved Patient Outcomes Using ABThera™ Negative Pressure Therapy System in Open Abdomen Surgery

SAN ANTONIO - Monday, August 26th 2013 [ME NewsWire]

(BUSINESS WIRE) Kinetic Concepts, Inc. announced today that results of the observational study, “Prospective Study Examining Clinical Outcomes Associated with a Negative Pressure Wound Therapy System and Barker’s Vacuum Packing Technique” is published in the September 2013 print edition of the World Journal of Surgery.1 These results, published online in May 2013, showed that ABThera™ Open Abdomen Negative Pressure Therapy System (ABThera™ OA NPT) was associated with significantly improved patient outcomes compared to traditional Barker’s vacuum-packing technique (BVPT) in trauma and surgical patients studied.

“Used as part of a comprehensive approach to open abdomen management, ABThera™ OA NPT was associated with a significantly lower mortality rate, increased abdominal closure rate and improved overall patient outcome,” said Michael Cheatham, MD, Corporate Chairman of Surgery, Orlando Health, and lead author of the study.

In the ABTAC study, 280 trauma and surgical patients who required temporary abdominal closure (TAC) following a damage control laparotomy or treatment of either intra-abdominal hypertension or severe sepsis, were enrolled from 20 sites across the US. Among patients treated with at least 48 hours of consistent TAC therapy (ABThera™ OA NPT n=111; BVPT n=57), the rate of primary fascial closure within 30 days was 69 percent for the ABThera™ OA NPT group and 51 percent for the BVPT (p=0.03). In this same patient group, the 30-day all-cause mortality rate was 14 percent for patients treated with ABThera™ OA NPT and 30 percent for those treated with BVPT (p=0.01). Multivariate logistic regression analysis identified that patients treated with ABThera™ Therapy were 3.2 times more likely to survive up to 30 days compared to BVPT patients [(95 percent confidence interval); p=0.02] after controlling for age, severity of illness and cumulative fluid administration.

“These dramatic and highly significant results underscore the value of ABThera™ Therapy in improving the management of patients with an open abdomen, a complex and often life-threatening condition,” said Ron Silverman, MD, chief medical officer, KCI.

The ABThera™ Open Abdomen Negative Pressure Therapy System is indicated for temporary bridging of abdominal wall openings where primary closure is not possible and repeat abdominal entries are necessary. This system is intended for use in open abdominal wounds with exposed viscera including, but not limited to, abdominal compartment syndrome. The intended care setting is a closely monitored area within the acute care hospital, such as the ICU. The abdominal dressing will most often be applied in the operating theater.

For more information about the ABThera™ Open Abdomen Negative Pressure Therapy System, including important safety information, please visit www.ABThera.com. To access the online version of the article, please click here.

About KCI

KCI is a leading global medical technology company devoted to understanding, developing and commercializing innovative, high-technology transformational healing solutions for customers and patients in more than 65 countries around the world. Headquartered in San Antonio, Texas, KCI is committed to advancing the science of healing and positively affecting patient care by developing customer-driven innovations to meet the evolving needs of healthcare professionals. Proprietary KCI negative pressure technologies have revolutionized the way in which caregivers treat a wide variety of wound types. The V.A.C.® Therapy System has been used on more than 7 million wounds worldwide. Additional information about KCI and its products is available at www.KCI1.com.

1Cheatham ML, Demetriades D, Fabian TC, et al. Study Examining Clinical Outcomes Associated with a Negative Pressure Wound Therapy System and Barker’s Vacuum Packing Technique. World Journal of Surgery. 2013 September; 37(9):2018-2030

Contacts
KCI Corporate Communications
Mike Barger, 210-255-6824
mike.barger@kci1.com









Permalink: http://www.me-newswire.net/news/8327/en

ESC Congress 2013: New data provide evidence for the positive safety and efficacy profile of Pradaxa in various atrial fibrillation patient populations

ME Newswire/ Business Wire

INGELHEIM, Germany - Monday, August 26th 2013

For media outside of the US, the UK & Canada only

Boehringer Ingelheim today announced the upcoming presentation of new data on the novel oral anticoagulant (NOAC) Pradaxa® (dabigatran etexilate) during the ESC Congress 2013 organised by the European Society of Cardiology (August 31 – September 4, Amsterdam, The Netherlands). The new data will add to the already available extensive body of knowledge on Pradaxa®’s positive safety and efficacy profile.

Boehringer Ingelheim remains committed to advancing the cardiology field and supporting physicians in their search for optimal stroke protection. Data being presented at the ESC Congress 2013 will complement the ongoing clinical trial programme of Pradaxa®, including results from the pivotal RE-LY® trial and the only long-term NOAC study, RELY-ABLE®, as well as new preclinical research on the company’s investigational antibody fragment antidote for dabigatran.

“The breadth of data being presented for Pradaxa® at this year’s ESC Congress 2013 demonstrates Boehringer Ingelheim’s continued dedication to improving the lives of patients with cardiovascular disorders. Our extensive and ongoing investment into clinical research will provide additional evidence on the positive efficacy and safety profile of Pradaxa® as well as important insights on its use in a wide range of patients and clinical settings”, said Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim.

Details of the key Pradaxa® abstracts being presented at the ESC Congress 2013 are listed below. Further information and the full list of abstracts can be found within the Scientific Programme, available at: http://spo.escardio.org/default.aspx?eevtid=60
                                   

TITLE
               

LEAD AUTHOR
               

DETAILS

Management of dyspepsia symptoms on dabigatran during RELY-ABLE: long-term follow up study after RE-LY
               

Robby Nieuwlaat (Hamilton, CA)
               

Poster Presentation ESC Number: P549 Poster Session 1: Arrhythmias – Pacing – Resynchronisation Date: 31 August Display Time: 14:00-18:00 Presentation Time: 15:30-16:30 Location: Posters – Village 9

Effects of the direct thrombin inhibitor dabigatran etexilate vs warfarin on platelet function in patients with atrial fibrillation
               

Giulia Renda (Chieti, IT)
               

Poster Presentation ESC Number: P1430 Poster Session 2: Treatment of Hypertension Date: 1 September Display Time: 08:30-12:30 Presentation Time: 10:00-11:00 Location: Posters – Village 9

RE-ALIGN: Dabigatran in patients with a mechanical heart valve
               

Frans Van de Werf (Leuven, BE)
               

Hot Line Presentation ESC Number: 937 Hot Line 1: Late Breaking Trials on Thrombosis Date: 1 September Time: 11:54-12:06 Location: Amsterdam – Central Village

Guidance adherent dabigatran etexilate treatment versus warfarin in the RE-LY population: an analysis on the basis of the European label recommendations for dabigatran etexilate
               

Gregory Y H Lip (Birmingham, GB)
               

Poster Presentation ESC Number: P4278 Poster Session 5: Atrial Fibrillation: New Insights Date: 2 September Display Time: 14:00-18:00 Presentation Time: 15:30-16:30 Location: Posters – Village 9

Reversal of dabigatran clotting activity in the rat ex vivo by a specific and selective antibody fragment antidote: are there non-specific effects on warfarin, rivaroxaban and apixaban?
               

Joanne Van Ryn (Biberach, DE)
               

Poster Presentation ESC Number: P4848 Poster Session 6: Thrombosis and Antithrombotic Therapy Date: 3 September Display Time: 08:30-12:30 Presentation Time: 10:00-11:00 Location: Posters – Village 9

Pradaxa® is widely approved for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and for primary prevention of VTE following total hip replacement or total knee replacement surgery.1 The extensive in-market experience of over 2 million patient-years in all licensed indications puts Pradaxa® first among the novel oral anticoagulants.2 In addition, Boehringer Ingelheim recently started submitting applications to regulatory authorities for the use of Pradaxa® in the acute treatment and prevention of recurrent deep vein thrombosis and pulmonary embolism.

Please click on the link below for ‘Notes to Editors’ and ‘References’: http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2013/26_august_2013_dabigatranetexilate.html

Contacts

Boehringer Ingelheim GmbH

Sara McClelland

Corporate Communications

Media + PR

Phone: +49 6132 – 77 8271

E-mail: press@boehringer-ingelheim.com

Twitter: http://twitter.com/Boehringer



More information

www.boehringer-ingelheim.com







Permalink: http://me-newswire.net/news/8331/en

ISNR 2014 a Comprehensive Platform to Discuss Security Issues and the Future Challenges

ABU DHABI, United Arab Emirates - Sunday, August 25th 2013 [ME NewsWire]

Major General Staff Dr. Obeid Al Hiri Salim Al Kutbi, Deputy Commander-in-Chief of Abu Dhabi Police and Chairman of the Higher Commission of the International Exhibition for Security and National Resilience (ISNR) Abu Dhabi 2014, stressed that the conference presents an important platform to look more closely at the latest concepts and specialized technologies in security, critical installations, and facility protection. He noted that it is a valuable opportunity to share experiences and experiments in terms of national security and safety in the Middle East and North Africa (MENA) region.

He added: “The comprehensive development in the United Arab Emirates (UAE) has realized consecutive successes and has transformed visions into reality in several fields and sectors. The progress includes a number of achievements representing a role model to be followed at both the regional and global levels.”

Major General Staff Al Kutbi mentioned: “Organizing the ISNR conference and exhibition in Abu Dhabi is in line with the on-going success of the emirate in hosting and organizing main international exhibitions and conferences. The emirate provides a highly developed and sophisticated infrastructure to the conferences and exhibitions industry. This has turned it into a global destination for major companies that are specialized in the sector.”

He noted that security and safety are the main pillars of society that reflect the aspirations of the UAE’s higher leadership in terms of the future of the country and its people. He said that this is the foundation of the commitment of the country’s leadership to keep pace with the highest standards in the security strategy. This strategy carries the aim of confronting the challenges that face development and modernization in the UAE.

“ISNR Abu Dhabi 2014 covers various issues related to national security, information security, firefighting, emergency response and occupational safety and health. This opens the doors for more cooperation with all our sisterly and friendly states, exhibitors and participating delegations,” he explained.

The Deputy Commander-in-Chief of Abu Dhabi Police commented that the international conference on security challenges held in conjunction with ISNR Abu Dhabi 2014 will discuss global security challenges that result from technological developments, and social and economic transformations. He noted that the event provides an opportunity to exchange experiences and the means by which to handle issues related to security. The event will also review success stories in this regard.

“We in the Emirate of Abu Dhabi are dedicated to maintaining pace with global developments, and applying the latest technologies in various fields especially in terms of security issues due to their direct impact on other sectors. No human, social or economic development can be achieved without stability and security, and we are fortunate that God granted us this wise leadership in the UAE.  Our leadership extends care to the protection of the nation and its achievements, ensures the dignity of the human being and its security, and protects the property of all citizens,” he concluded.

For more information about:

The Ministry of Interior, please click HERE

Abu Dhabi Police, please click HERE

Follow us and check our Social Media feeds on: YouTube, Facebook and Twitter

Photo Captions:

Photo 1:Major General Staff Dr. Obeid Al Hiri Salim Al Kutbi.

The Arabic-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the Arabic-language text, which is the only version of the text intended to have legal effect.

Contacts

The UAE Minister of Interior's General Secretariat, Tactical Affairs and Security Media Department

Abu Dhabi Police GHQ - Security Media

Chris Cron +971-(0)-50-987-1317

E-mail: cron.media@hotmail.com

Color Spot Nurseries Expands SAP Footprint with Rimini Street

Company Benefits from Significant Savings and More Robust Service Model for SAP Since 2010

LAS VEGAS - Saturday, August 24th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Rimini Street, Inc., the leading third-party maintenance and support provider for enterprise software, including SAP AG’s (NYSE: SAP) Business Suite and BusinessObjects software and Oracle Corporation’s (NYSE: ORCL) Siebel, PeopleSoft, JD Edwards, E-Business Suite, Oracle Database and Hyperion software, today announced that Color Spot Nurseries, a leading wholesale producer and distributor of specialty horticulture, has continued to successfully expand its SAP footprint to meet growing and changing business needs while leveraging Rimini Street Support since 2010. When it switched from SAP vendor support to Rimini Street Support more than three years ago, Color Spot greatly improved the level of support it receives for its SAP system, and at the same time, was able to cut its annual maintenance and support costs by more than 50 percent. The savings were used to drive strategic initiatives and to meet the ongoing needs of the business.

Color Spot Benefits from Rimini Street’s Innovative Support Model

Color Spot specializes in the production and distribution of high quality bedding plants, vegetables, herbs and shrubs to more than 2,000 retail and commercial customers around the US. Since 2001, the company has relied on its SAP R/3 4.7C implementation for mission-critical operations, including finance, human resources and payroll processes. The company also continues to grow aggressively through acquisitions and expand its SAP instance across all entities. After an internal audit in late 2009 showed that SAP vendor maintenance fees consumed over 20 percent of the total IT budget and did not deliver value commensurate with the support the company received, Color Spot’s Chief Information Officer, Eric Robinson, made the decision to switch from SAP to Rimini Street in 2010. Moreover, SAP had announced that it would no longer provide support for version 4.7C, which would have forced Color Spot to undergo an expensive, unneeded and disruptive upgrade to ECC 6.0, or else face de-support.

Through Rimini Street’s innovative, premium-level support model, Robinson immediately cut his maintenance budget by 50 percent, gained support for customizations at no additional cost and received guaranteed support for Color Spot’s existing SAP R/3 release for at least another decade. The switch to Rimini Street support for SAP has enabled Color Spot to avoid costly, disruptive upgrades that would have been performed for the sake of continuing support. Color Spot also utilizes the Rimini Street Tax Engine for SAP Payroll and receives regular tax, legal and regulatory updates and that keep the organization in compliance with changes taking place at the local, state and federal levels.

Color Spot Expands Use of SAP While Supported by Rimini Street

Color Spot has aggressively managed its business to optimize market opportunity and streamline internal operations while under Rimini Street Support for the past three years, including making acquisitions to enter or consolidate markets. To enable this growth and expansion, Color Spot has expanded its use of SAP, including the purchase and deployment of new SAP licenses and has relied on Rimini Street for support of its growing, changing SAP footprint.

“Three years ago, we made the critical decision to switch from SAP vendor support to Rimini Street and we couldn’t be happier with the decision and the results. Their support model works as advertised and we have been able to achieve great success, including reducing our software maintenance costs from 20 percent to only 9 percent of my overall IT budget, and significantly improving the level of support we receive,” said Robinson. “Today, Rimini Street is much more than a vendor – I consider them a valued partner and extension of my IT team, especially during this important period of growth and expansion.”

Rimini Street Dedicated to Delivering Industry’s Best Support Service

Since 2005, more than 660 organizations around the world, including 75 of the Fortune 500 and 16 of the Global 100, have leveraged Rimini Street for their Oracle and SAP systems to reduce total support costs by up to 90 percent, while continuing to advance the scope, scale and use of their enterprise software to achieve critical business objectives. Rimini Street’s more efficient, personalized support program includes 24X7X365 support, an assigned Primary Support Engineer (PSE), support for customizations at no additional fee and support for a minimum of 10 years for existing releases without any required upgrades.

“Rimini Street set out to provide SAP licensees around the world with a more relevant and value-driven software maintenance option. Today, we are proud to be an integral partner to Color Spot and many other SAP licensees,” said Seth Ravin, CEO, Rimini Street. “Now with more than 660 clients signed, Rimini Street is the proven leader in third-party support for both Oracle and SAP licensees, and will continue to dedicate itself to providing all of our clients with the most innovative, ultra-responsive enterprise software support in the industry for the long-term.”

About Rimini Street, Inc.

Rimini Street is the leading third-party provider of enterprise software support services. The company is redefining enterprise support services with an innovative, award-winning program that enables Oracle and SAP licensees to save up to 90 percent on total support costs over a decade, including saving 50 percent on annual support fees. Clients can remain on their current software release without any required upgrades or migrations for at least 10 years. Hundreds of global, Fortune 500, midmarket, and public sector organizations from virtually all industries have selected Rimini Street as their trusted, independent support provider. To learn more, please visit www.riministreet.com or call within the USA 888-870-9692 or internationally +1 702-839-9671.

Rimini Street and the Rimini Street logo are trademarks of Rimini Street, Inc. All other company and product names may be trademarks of their respective owners. Copyright © 2013. All rights reserved.

Contacts

Rimini Street, Inc.

Alma Park, +1 323-229-7282

apark@riministreet.com


Permalink: http://www.me-newswire.net/news/8318/en

Toshiba Starts Second Phase Construction of No. 5 Semiconductor Fabrication Facility at Yokkaichi

TOKYO - Friday, August 23rd 2013 [ME NewsWire]

(BUSINESS WIRE) Toshiba Corporation (TOKYO:6502) today held a groundbreaking ceremony in readiness for the start of construction of Phase 2 of Fab 5, the company’s state-of-the-art fabrication facility (fab) at its Yokkaichi Operations memory production facility in Mie Prefecture.

Toshiba will expand Fab 5 to secure manufacturing space for NAND flash memories fabricated with next generation process technology and for 3D memories. Construction will be completed in summer next year, and decisions on equipment investments and production levels will reflect market trends.

Three fabs at Yokkaichi Operations currently mass produce NAND flash memories, including Fab 5 phase 1. Fab 5’s construction was planned around two phases, the first of which went into operation in July 2011. After giving careful consideration to the balance of product supply and demand, and noting a recovery driven by growing demand for smartphones, tablets, SSD for enterprise servers, Toshiba now anticipates further medium- to long-term market expansion and recognizes that the time is right to expand Fab 5.

Going forward, Toshiba will expand business and boost competitiveness by leadership in advanced process technology and the development of new generation memories that answer market needs.


Outline of Fab 5

Structure of building:
         

2-story steel frame concrete, five floors

Ground area:
         

Approximately 38,000m2

Total floor area:
         

Approximately 187,000m2

Start of Construction:
         

First Phase: July 2010
           

Second Phase: August 2013

Completion:
         

First Phase: May 2011
           

Second Phase: Summer 2014 (target)

Start of Production:
         

First Phase: July 2011
           

Second Phase: To be determined later; intended primarily for technology transition of existing wafer capacity


Outline of Yokkaichi Operations

Location:
         

800, Yamanoisshiki-cho, Yokkaichi, Mie Prefecture

Established:
         

January 1992

General Manager:
         

Tomoharu Watanabe

Employees:
         

Approximately 5,200
           

(as of end of March, 2013, regular employees of Toshiba)

Site area:
         

Approximately 436,800 m2 (including Fab 5)

Total floor area:
         

Approximately 647,000m2 (including Fab 5)


About Toshiba

Toshiba is a world-leading diversified manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba Group brings innovation and imagination to a wide range of businesses: digital products, including LCD TVs, notebook PCs, retail solutions and MFPs; electronic devices, including semiconductors, storage products and materials; industrial and social infrastructure systems, including power generation systems, smart community solutions, medical systems and escalators & elevators; and home appliances.

Toshiba was founded in 1875, and today operates a global network of more than 590 consolidated companies, with 206,000 employees worldwide and annual sales surpassing 5.8 trillion yen (US$61 billion). Visit Toshiba's web site at www.toshiba.co.jp/index.htm

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130822006257/en/

Contacts

Toshiba Corporation
Semiconductor & Storage Products Company
Megumi Genchi / Kota Yamaji, +81-3-3457-3576
Communication IR Promotion Group
Business Planning Division
semicon-NR-mailbox@ml.toshiba.co.jp









Permalink: http://www.me-newswire.net/news/8317/en